INFANTILE MIOFIBROMATOSIS IN NEWBORN: CASE REPORT
https://doi.org/10.22627/2072-8107-2017-16-2-63-67
Abstract
The article describes the clinical case of infantile myofibromatosis of a newborn child. Infantile myofibromatosis is a rare mesenchymal tumor of the soft tissues of the head, limbs, trunk in children with infiltrative local growth, without metastases. During the examination the patient was diagnosed multiple myofibroms, which had a tendency to increase in the combination of active herpes infection. In this case, does not exclude the impact of mixed herpetic infection on the growth of myofibroms as on the background of antiviral treatment showed positive dynamics with a decrease in the number and size of tumors.
About the Authors
N. V. Biherl
Scientific and Practical Center of Special Medical Care
Russian Federation
Natalia V. Biherl, leading researcher, PhD
Russian Federation
Natalia V. Biherl, leading researcher, PhD
M. S. Savenkova
Scientific and Practical Center of Special Medical Care
Russian Federation
Moscow
Russian Federation
Moscow
Yu. L. Ischutina
Scientific and Practical Center of Special Medical Care
Russian Federation
Moscow
Russian Federation
Moscow
M. P. Schalatonin
Morozovskaya Children's City Clinical Hospital
Russian Federation
Russian Federation
S. S. Gylina
Scientific and Practical Center of Special Medical Care
Russian Federation
Moscow
Russian Federation
Moscow
K. F. Savlaev
Scientific and Practical Center of Special Medical Care
Russian Federation
Moscow
Russian Federation
Moscow
Yu. V. Gritsova
Scientific and Practical Center of Special Medical Care
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Близнюков О.П., Смирнова Е.А., Пономарева М.В., Козлов Н.А. Инфантильная миофиброма (ИМ), гистологическое строение, ультраструктура, клиническое течение. Вопросы онкологии (СП). 2010; 56(4): 435—442. [Bliznyukov O.P., Smirnova E.A., Ponomareva M.V., Kozlov N.A. Infantile myofibroma (MI), histological structure, ultrastructure, clinical course. Oncology Questions (SP). 2010; 56 (4): 435—442. (In Russ.)]
2. Arts F.A., Chand D., Pecquet C., Velghe A.I., Constantinescu S., Hallberg B., Demoulin J.B. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib. Oncogene. 2016 Jun 23; 35(25): 3239—48.
3. Cheung Y.H., Gayden T., Campeau P.M., LeDuc C.A. et al. A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Am J Hum Genet. 2013 Jun 6; 92(6): 996—1000. doi: 10.1016/j.ajhg. 2013.04.026.
4. Martignetti J.A., Tian L., Li D., Ramirez M.C., Camacho-Vanegas O. et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet. 2013 Jun 6; 92(6): 1001—7. doi: 10.1016/j.ajhg.2013.04.024.
5. Levine E., Freneaux P., Schleiermacher G., Brisse H., Pannier S., Teissier N., Mesples B., Orbach D. Risk-adapted therapy for infantile myofibromatosis in children. Pediatr Blood Cancer. 2012 Jul 15; 59(1): 115—20. doi: 10.1002/pbc.23387.
6. Wu W., Chen J., Cao X., Yang M., Zhu J., Zhao G. Solitary infantile myofibromatosis in the bones of the upper extremities: Two rare cases and a review of the literature. Oncol Lett. 2013 Nov; 6(5): 1406— 1408.
7. Weaver M.S., Navid F., Huppmann A., Meany H., Angiolillo A. Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options. J Pediatr Hematol Oncol. 2015 Apr; 37(3): 237—41. 8. Wu S.Y., McCavit T.L., Cederberg K., Galindo R.L., Leavey P.J. Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement. J Pediatr Hematol Oncol. 2015 Jul; 37(5): 402—5. doi: 10.1097/MPH.0000000000000132.
Review
For citations:
Biherl N.V., Savenkova M.S., Ischutina Yu.L., Schalatonin M.P., Gylina S.S., Savlaev K.F., Gritsova Yu.V. INFANTILE MIOFIBROMATOSIS IN NEWBORN: CASE REPORT. CHILDREN INFECTIONS. 2017;16(2):63-67. (In Russ.) https://doi.org/10.22627/2072-8107-2017-16-2-63-67
Views:
1708
Email this article 